ALVO
Price
$5.75
Change
+$0.22 (+3.98%)
Updated
Dec 11 closing price
Capitalization
1.79B
110 days until earnings call
Intraday BUY SELL Signals
LIEN
Price
$10.79
Change
+$0.13 (+1.22%)
Updated
Dec 12, 11:57 AM (EDT)
Capitalization
243.27M
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALVO vs LIEN

Header iconALVO vs LIEN Comparison
Open Charts ALVO vs LIENBanner chart's image
Alvotech
Price$5.75
Change+$0.22 (+3.98%)
Volume$600.46K
Capitalization1.79B
Chicago Atlantic BDC
Price$10.79
Change+$0.13 (+1.22%)
Volume$100
Capitalization243.27M
ALVO vs LIEN Comparison Chart in %
ALVO
Daily Signal:
Gain/Loss:
LIEN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALVO vs. LIEN commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and LIEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (ALVO: $5.75 vs. LIEN: $10.66)
Brand notoriety: ALVO and LIEN are both not notable
ALVO represents the Pharmaceuticals: Generic, while LIEN is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: ALVO: 98% vs. LIEN: 106%
Market capitalization -- ALVO: $1.79B vs. LIEN: $243.27M
ALVO [@Pharmaceuticals: Generic] is valued at $1.79B. LIEN’s [@Investment Managers] market capitalization is $243.27M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The market cap for tickers in the [@Investment Managers] industry ranges from $170.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.29B. The average market capitalization across the [@Investment Managers] industry is $7.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 0 FA rating(s) are green whileLIEN’s FA Score has 1 green FA rating(s).

  • ALVO’s FA Score: 0 green, 5 red.
  • LIEN’s FA Score: 1 green, 4 red.
According to our system of comparison, LIEN is a better buy in the long-term than ALVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 5 TA indicator(s) are bullish while LIEN’s TA Score has 3 bullish TA indicator(s).

  • ALVO’s TA Score: 5 bullish, 3 bearish.
  • LIEN’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ALVO is a better buy in the short-term than LIEN.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а +13.41% price change this week, while LIEN (@Investment Managers) price change was +0.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.50%. For the same industry, the average monthly price growth was -1.01%, and the average quarterly price growth was +19.25%.

The average weekly price growth across all stocks in the @Investment Managers industry was +0.54%. For the same industry, the average monthly price growth was +0.36%, and the average quarterly price growth was +11.51%.

Reported Earning Dates

ALVO is expected to report earnings on Apr 01, 2026.

LIEN is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.50% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Investment Managers (+0.54% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($1.79B) has a higher market cap than LIEN($243M). ALVO has higher P/E ratio than LIEN: ALVO (25.00) vs LIEN (6.06). LIEN YTD gains are higher at: -3.881 vs. ALVO (-56.538). ALVO has more cash in the bank: 151M vs. LIEN (5.4K). LIEN has less debt than ALVO: LIEN (5M) vs ALVO (1.27B). ALVO has higher revenues than LIEN: ALVO (560M) vs LIEN (31.4M).
ALVOLIENALVO / LIEN
Capitalization1.79B243M737%
EBITDA207MN/A-
Gain YTD-56.538-3.8811,457%
P/E Ratio25.006.06413%
Revenue560M31.4M1,783%
Total Cash151M5.4K2,796,296%
Total Debt1.27B5M25,360%
TECHNICAL ANALYSIS
Technical Analysis
ALVOLIEN
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 3 days ago
49%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
49%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 8 days ago
64%
Bullish Trend 5 days ago
52%
Declines
ODDS (%)
Bearish Trend 15 days ago
69%
Bearish Trend 3 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ALVO
Daily Signal:
Gain/Loss:
LIEN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREAX6.680.04
+0.60%
PACE Global Real Estate Securities A
DWUSX19.170.08
+0.42%
DFA World ex US Targeted Val Instl
KCGIX25.400.02
+0.08%
Knights of Columbus Large Cap Growth I
PASTX65.24-0.48
-0.73%
T. Rowe Price Science & Tech Adv
SCGSX130.44-9.89
-7.05%
DWS Capital Growth S

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+3.98%
EBS - ALVO
31%
Poorly correlated
+1.38%
CRON - ALVO
27%
Poorly correlated
+2.15%
PAHC - ALVO
26%
Poorly correlated
+2.23%
VTRS - ALVO
22%
Poorly correlated
-0.09%
ACB - ALVO
22%
Poorly correlated
+0.44%
More

LIEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIEN has been loosely correlated with TXMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LIEN jumps, then TXMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIEN
1D Price
Change %
LIEN100%
+0.33%
TXMD - LIEN
36%
Loosely correlated
-2.13%
AVDL - LIEN
24%
Poorly correlated
-0.42%
SHPH - LIEN
21%
Poorly correlated
-3.24%
BBUC - LIEN
13%
Poorly correlated
+1.82%
BAM - LIEN
12%
Poorly correlated
-1.92%
More